Glenmede Trust CO Na Pfizer Inc Transaction History

Glenmede Trust CO Na

$20.6 Billion
Q3 2024

A detailed history of Glenmede Trust CO Na transactions in Pfizer Inc stock. As of the latest transaction made, Glenmede Trust CO Na holds 1,067,929 shares of PFE stock, worth $28.2 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

1,067,929

Previous 1,096,143 2.57%

Holding current value

$28.2 Million

Previous $30.7 Million 0.77%

% of portfolio

0.15%

Previous 0.16%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$27.7 - $31.39 $781,527 - $885,637	-28,214 Reduced 2.57%	1,067,929 $30.9 Million
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $392,894 - $460,398	15,554 Added 1.44%	1,096,143 $30.7 Million
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $7.24 Million - $8.32 Million	-279,699 Reduced 20.56%	1,080,589 $30 Million
Q4 2023 Feb 13, 2024	SELL	$26.13 - $33.94 $6.16 Million - $8 Million	-235,681 Reduced 14.77%	1,360,288 $39.2 Million
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $17.4 Million - $20.3 Million	-541,022 Reduced 25.32%	1,595,969 $52.9 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $22,286 - $25,784	-617 Reduced 0.03%	2,136,991 $78.4 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $7.09 Million - $9.23 Million	-180,084 Reduced 7.77%	2,137,608 $87.2 Million
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $2.34 Million - $3.05 Million	56,043 Added 2.48%	2,317,692 $119 Million
Q3 2022 Nov 16, 2022	SELL	$43.76 - $53.42 $18.3 Million - $22.3 Million	-417,828 Reduced 15.59%	2,261,649 $99 Million
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $1.46 Million - $1.74 Million	31,480 Added 1.19%	2,679,477 $140 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $10.9 Million - $13.5 Million	238,858 Added 9.91%	2,647,997 $137 Million
Q4 2021 Feb 15, 2022	BUY	$41.32 - $61.25 $1.65 Million - $2.45 Million	39,954 Added 1.69%	2,409,139 $142 Million
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $2.32 Million - $2.98 Million	-59,055 Reduced 2.43%	2,369,185 $102 Million
Q2 2021 Aug 16, 2021	SELL	$35.91 - $40.68 $9.81 Million - $11.1 Million	-273,063 Reduced 10.11%	2,428,240 $95.1 Million
Q1 2021 May 18, 2021	SELL	$33.49 - $37.77 $25.7 Million - $29 Million	-766,954 Reduced 22.11%	2,701,303 $97.9 Million
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $11.5 Million - $14.7 Million	344,369 Added 11.02%	3,468,257 $128 Million
Q3 2020 Nov 16, 2020	BUY	$31.75 - $37.25 $7.55 Million - $8.86 Million	237,831 Added 8.24%	3,123,888 $115 Million
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $14.7 Million - $17.8 Million	-486,476 Reduced 14.42%	2,886,057 $94.4 Million
Q4 2019 Feb 12, 2020	BUY	$32.92 - $37.36 $20.8 Million - $23.6 Million	631,550 Added 23.04%	3,372,533 $132 Million
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $57 Million - $73.9 Million	-1,753,919 Reduced 39.02%	2,740,983 $98.5 Million
Q2 2019 Aug 13, 2019	BUY	$36.98 - $41.52 $20.1 Million - $22.6 Million	543,198 Added 13.75%	4,494,902 $195 Million
Q1 2019 May 14, 2019	SELL	$37.5 - $41.2 $43 Million - $47.2 Million	-1,145,719 Reduced 22.48%	3,951,704 $168 Million
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $2.31 Million - $2.64 Million	-60,159 Reduced 1.17%	5,097,423 $223 Million
Q3 2018 Nov 15, 2018	BUY	$34.47 - $41.81 $63.8 Million - $77.4 Million	1,850,392 Added 55.95%	5,157,582 $227 Million
Q2 2018 Aug 15, 2018	BUY	$32.98 - $35.16 $5.54 Million - $5.91 Million	168,129 Added 5.36%	3,307,190 $120 Million
Q4 2017 Feb 15, 2018	BUY	$33.26 - $35.29 $28.7 Million - $30.4 Million	861,492 Added 37.83%	3,139,061 $114 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $70.6 Million - $77.8 Million	2,277,569	2,277,569 $0

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.

Account

Glenmede Trust CO Na Pfizer Inc Transaction History